An HIV breakthrough is here. Let's not let it go to waste
|
Lenacapavir is not new. The antiretroviral drug was
first approved in 2022 for treating people living with HIV who were highly
resistant to other ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.